explore -WSS

explore

author：comprehensive 2025-10-01 18:33:11 - browse：3

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： FDA panel issues narrow recommendation for Covid vaccine booster doses

WSS

American woman, child freed after being kidnapped in Haiti last month

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

What the US credit downgrade means for the economy, your finances

Naloxone nonprofit donates 200,000 doses after FDA approval

Micronoma's microbiome cancer diagnostic approach under fire

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

hotspot

explore

explore

The high cost of giving birth even with insurance

Lawsuit alleges UnitedHealth Group unit illegally denied claims

United colonoscopy coverage change 'may cost lives,' doctors say

Why failed clinical trials don’t always spell doom for a new drug

Activists slam private health insurers over coverage restrictions

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Affirmative action in medical school literally saved lives

A biotech analyst on neuroscience, placebo effect, not over

Novavax promises a turnaround & Lilly roils the obesity market

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

focus

A biotech analyst on neuroscience, placebo effect, not over

Maui's cultural, historic landmarks damaged in the devastating wildfires

Wildfire pollution widens asthma inequities on Long Island

Emergent cuts jobs, executive role in business shake

Anavex keeps shifting the goalposts in its clinical trials

Police still searching for prisoner who escaped from NYC hospital

leisure time

entertainment

knowledge

hotspot